Open AccessCytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
Author(s) -
Brunangelo Falini,
Dido Lenze,
Robert P. Hasserjian,
Sarah E. Coupland,
D. Jaehne,
Chad P. Soupir,
Arcangelo Liso,
Maria Paola Martelli,
Niccolò Bolli,
Francesco Bacci,
Valentina Pettirossi,
A Santucci,
Massimo F. Martelli,
Stefano Pileri,
Harald Stein
Publication year - 2007
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/sj.leu.2404699
Subject(s) - nucleophosmin , myeloid , hematology , myeloid leukemia , cytoplasm , biology , medicine , cancer research , pathology , genetics